The US Food and Drug Administration (FDA) has approved Vetoquinol USA’s Imoxi Topical Solution for Cats.
The FDA announced a recall of a sedative commonly used in the treatment of human COVID patients—and by some veterinarians as an anxiolytic.
This week: A cat in the UK tests positive for COVID, a vet loses his license to practice medicine, and the pandemic inspires more people to adopt pet chickens.
The CDC and the USDA announced last week the first confirmed cases of SARS-CoV-2 infection in two pet cats in New York State. In the wake of that announcement, the CDC now recommends that pet owners follow the same social distancing guidelines with their pets as with human family members.
In most places, the COVID vaccine rollout is confused at best. Vet med professionals share their vaccination frustrations and successes.
As states begin to authorize veterinarians to administer COVID vaccinations (should the need arise), some might ask, “What’s in it for me?” Potentially, a vaccination.
Pentobarbital solution—the go-to drug for companion-animal euthanasia—has been in short supply for months. But Kathleen Cooney, DVM, MS, CHPV, CCFP, says there’s no reason you would have known that “unless you do a lot of euthanasias.”
With mask restrictions now lifted in most US states and most states scheduled to be fully open with a few restrictions by July 4, many veterinary professionals are wondering what’s on the horizon as far as safety protocols.
The warning letter is only the latest step in a story that’s been unfolding since late last year when the company issued a voluntary pet food recall due to reports of possible aflatoxin contamination.
Xylitol-related calls to pet poison hotlines have skyrocketed in recent years. The Paws Off Act of 2021, which would require food products containing xylitol to include a warning label, could help.